....hmm, ....ImmunoGen's Net income for the third quarter of 2023 was $30.7 million and it had $605.5 million in cash and cash equivalents and $130.7 million in accounts receivable as of September 30, 2023....
Progressing at this pace of development Patrys may get to replicate those figures pretty soon and hopefully before the 100th anniversary of the Stockholm syndrome....
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.2¢ |
Change
0.000(0.00%) |
Mkt cap ! $4.731M | |||
| Open | High | Low | Value | Volume |
| 0.2¢ | 0.2¢ | 0.2¢ | $3.509K | 1.754M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 46 | 104890723 | 0.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 54489518 | 26 |
View Market Depth
| Last trade - 16.10pm 30/07/2025 (20 minute delay) ? |
| PAB (ASX) Chart |